1. 102P A multicenter retrospective cohort study comparing the efficacy and safety of lenvatinib in combination with PD-1 inhibitor with or without transarterial chemoembolization in patients with unresectable hepatocellular carcinoma. (December 2022) Authors: Tan, G.; Lin, J.; Wen, F.; Chi, M.; Yu, G.; Lin, Z.; Ning, Z. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 185 Preventing Urinary Fistulae After Artificial Urinary Sphincter Removal: Outcomes of a Standardized Protocol. Issue 1 (1st April 2022) Authors: Lin, J.; Ginsberg, D.; Doumanian, L.; Boyd, S.; Loh-Doyle, J. Journal: Journal of sexual medicine Issue: Volume 19:Issue 1(2022)Supplement Page Start: S93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 222 FACTORS AFFECTING TRANSFUSION AMOUNTS IN PATIENTS WITH ACUTE LEUKEMIA AND ACUTE LEUKEMIA WITH MYELODYSPLASIA: A NATIONWIDE DATABASE STUDY. Issue 1 (April 2015) Authors: Lin, J.; Chiou, T. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 222 IMPROVING PREVENTIVE CARE: ASSESSING ADHERENCE TO THE SIXTH AMERICAN COLLEGE OF CHEST PHYSICIANS' RECOMMENDATIONS FOR THROMBOPROPHYLAXIS IN AT-RISK CARDIOVASCULAR AND STROKE PATIENTS IN US HOSPITALS. Issue 1 (1st January 2007) Authors: Amin, A. N.; Stemkowski, S. A.; Lin, J.; Yang, G. Journal: Journal of investigative medicine Issue: Volume 55:Issue 1(2007) Page Start: S112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis. (September 2015) Authors: Alekseev, B.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2634 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis. (September 2015) Authors: Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Li, H.; Alekseev, B.; Xie, L.; Kurteva, G.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Cosgriff, T.; Collins, L.; Brechenmacher, T.; Lin, J.; Morgan, L.; Motzer, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 3D bone-shape changes and their correlations with cartilage T1ρ and T2 relaxation times and patient-reported outcomes over 3-years after ACL reconstruction. Issue 6 (June 2019) Authors: Zhong, Q.; Pedoia, V.; Tanaka, M.; Neumann, J.; Link, T.M.; Ma, B.; Lin, J.; Li, X. Journal: Osteoarthritis and cartilage Issue: Volume 27:Issue 6(2019) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 630POptimal extent of abdominal lymph node dissection for advanced Siewert type II and III esophagogastric junction carcinoma. (18th September 2017) Authors: Lin, J.; Chang-Ming, H.; Zheng, C.; Li, P.; Xie, J. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 76P Safety profile of adjuvant pembrolizumab (pembro) in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC): Pooled analysis of phase III clinical trials. (December 2022) Authors: Luke, J.J.; Long, G.V.; Robert, C.; Carlino, M.S.; Choueiri, T.K.; Haas, N.B.; O'Brien, M.E.R.; Paz-Ares, L.; Peters, S.; Powles, T.B.; Leiby, M.A.; Lin, J.; Zhao, Y.; Krepler, C.; Perini, R.F.; Pietanza, M.C.; Samkari, A.; Gruber, T.; Ibrahim, N.; Eggermont, A.M.M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. [BP.08.02] THE ROLE OF SIRT3 MEDIATED ENDOTHELIAL TO MESENCHYMAL TRANSITION IN HYPERTENSIVE RENAL FIBROSIS. (September 2017) Authors: Lin, J.; Shen, W.; Wei, T.; Gao, P. Journal: Journal of hypertension Issue: Volume 35(2017)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗